Assembly Biosciences (ASMB) traded down -0.86 % during a 24 hours period ending at 05:34 AM Central Europe on Wednesday 28th. One Assembly Biosciences stock can currently be bought for about USD 20.3 on popular exchanges. Current supply of Assembly Biosciences stocks is 20.4 mn. Assembly Biosciences has a current market capitalization of USD 402.2 mn and approximately USD 3 mn worth of Assembly Biosciences was traded on exchanges in the last 24 hours. Since last month end, Assembly Biosciences has traded -16.69 % down. Simple moving average of last 200 days is at USD 27.42. The highest price of past 52 weeks was recorded at USD 39.71 on 11/20/2025. 52 weeks low was at USD 19.3 on 10/23/2026.
Here is how related stocks have performed in the past 24 hours:
B&r Merger (BRTMU) traded down -6.15 % and now trades at USD 9.95. Current market capitalisation for B&r Merger is USD 477.2 mn.
Arvinas (ARVN) traded up 0.14 % and now trades at USD 7.45. Arvinas has a market capitalisation of USD 479.9 mn. Current price/earnings ratio for Arvinas is 54.38.
Cerus (CERS) traded up 1.72 % and now trades at USD 2.4. Cerus has a market capitalisation of USD 475.6 mn.
Monopar Therapeutics (MNPR) traded down -0.16 % and now trades at USD 71.84. Current market capitalisation for Monopar Therapeutics is USD 479.5 mn.
Avita Medical (RCEL) traded flat 0 % and now trades at USD 16.08. Current market capitalisation for Avita Medical is USD 479.7 mn.
About Assembly Biosciences
Assembly Biosciences Inc. is a biopharmaceutical company that specializes in the field of infectious diseases, particularly focusing on the Hepatitis B virus (HBV) and clostridium difficile (CDAD). The company has two proprietary platforms in development: an HBV-cure platform focused on oral drugs with novel direct-acting mechanisms, and an orally-delivered microbiome therapeutics platform for treating CDAD.